Because it has been reported that activation of NF-κB signaling in intestinal epithelial cells and lamina propria macrophages play a major role in the development of colitis-associated cancer (CAC) in humans [11], this study indicates that DHMEQ or its derivatives may have an implication in CRC prevention and therapy. This evidence concerns the gene NFKB1 and colorectal carcinoma.